Emergence of SARS-CoV-2 and its outlook
Global Health & Medicine. 2020; 2(1):1-2.
Sustaining containment of COVID-19: global sharing for pandemic response
Global Health & Medicine. 2020; 2(2):53-55.
Scientific solidarity in the face of the COVID-19 pandemic: researchers, publishers, and medical associations
Global Health & Medicine. 2020; 2(2):56-59.
Call for international cooperation and collaboration to effectively tackle the COVID-19 pandemic
Global Health & Medicine. 2020; 2(2):60-62.
Challenges of COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan: a real-world story
Global Health & Medicine. 2020; 2(2):63-65.
Guidelines for the diagnosis and treatment of coronavirus disease 2019 (COVID-19) in China
Global Health & Medicine. 2020; 2(2):66-72.
The COVID-19 pandemic preparedness ... or lack thereof: from China to Italy
Global Health & Medicine. 2020; 2(2):73-77.
Coronavirus disease 2019 (COVID-19): research progress and clinical practice
Global Health & Medicine. 2020; 2(2):78-88.
COVID-19 in China: the role and activities of Internet-based healthcare platforms
Global Health & Medicine. 2020; 2(2):89-95.
Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan
Global Health & Medicine. 2020; 2(2):96-101.
Epidemiology and quarantine measures during COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan in 2020: a descriptive analysis
Global Health & Medicine. 2020; 2(2):102-106.
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine
Global Health & Medicine. 2020; 2(2):107-111.
Epidemiological features after emergency declaration in Hokkaido and report of 15 cases of COVID-19 including 3 cases requiring mechanical ventilation
Global Health & Medicine. 2020; 2(2):112-117.
Early cases of COVID-19 in Tokyo and occupational health
Global Health & Medicine. 2020; 2(2):118-122.
Rapid spread of COVID-19 in New York and the response of the community
Global Health & Medicine. 2020; 2(2):123-126.
Nursing care for patients with COVID-19 on extracorporeal membrane oxygenation (ECMO) support
Global Health & Medicine. 2020; 2(2):127-130.
Japanese strategy to COVID-19: How does it work?
Global Health & Medicine. 2020; 2(2):131-132.
Response to the COVID-19 epidemic: a report from Shenzhen, China
Global Health & Medicine. 2020; 2(2):133-134.
COVID-19 outbreak and surgeons’ response at a Cancer Center in the United States
Global Health & Medicine. 2020; 2(2):135-137.
The National Health Service (NHS) response to the COVID-19 pandemic: a colorectal surgeon’s experience in the UK
Global Health & Medicine. 2020; 2(2):138-139.
Can we apply lessons learned from Ebola experience in West Africa for COVID-19 in lower income countries?
Global Health & Medicine. 2020; 2(2):140-141.
Challenges to neonatal care in Cambodia amid the COVID-19 pandemic
Global Health & Medicine. 2020; 2(2):142-144.
The necessity of continuous international cooperation for establishing the coronavirus disease 2019 diagnostic capacity despite the challenges of fighting the outbreak in home countries
Global Health & Medicine. 2020; 2(2):145-147.
Sustainable implementation of international health cooperation projects while Japanese technical experts cannot go to low- and middle-income countries because of the COVID-19 pandemic travel restrictions
Global Health & Medicine. 2020; 2(2):148-150.
COVID-19 can suddenly become severe: a case series from Tokyo, Japan
Global Health & Medicine. 2020; 2(3):174-177.
A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan
Global Health & Medicine. 2020; 2(3):190-192.
Corticosteroid therapy for severe COVID-19 pneumonia: optimal dose and duration of administration
Global Health & Medicine. 2020; 2(3):193-196.
COVID-19: emerging challenges for oncological surgery
Global Health & Medicine. 2020; 2(3):197-199.
FDG-PET/CT images of COVID-19: a comprehensive review
Global Health & Medicine. 2020; 2(4):221-226.
Identifying medical professionals at risk for in-hospital COVID-19 infection: a snapshot during a "tsunami" highlighting unexpected risks
Global Health & Medicine. 2020; 2(4):235-239.
Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs)
Global Health & Medicine. 2020; 2(6):343-345.
A SARS-CoV-2 antiviral therapy score card
Global Health & Medicine. 2020; 2(6):346-349.
COVID-19 handling report for pre-case, case (pre-hospital and hospital), and post-case phases in the elderly as vulnerable populations in 6 Asia Pacific countries
Global Health & Medicine. 2020; 2(6):350-359.
Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic
Global Health & Medicine. 2020; 2(6):392-394.
Using flowchart for ophthalmic consultations in hospitalized patients with COVID-19
Global Health & Medicine. 2020; 2(6):395-397.
COVID-19 vaccines: implementation, limitations and opportunities
Global Health & Medicine. 2021; 3(1):1-5.
Hospital capacity during the COVID-19 pandemic
Global Health & Medicine. 2021; 3(2):56-59.
SARS-CoV-2 surreptitiously injures the heart of Japanese: echocardiography is useful in evaluating cardiac damage
Global Health & Medicine. 2021; 3(2):60-61.
Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan
Global Health & Medicine. 2021; 3(2):62-66.
COVID-19 and bronchial asthma: current perspectives
Global Health & Medicine. 2021; 3(2):67-72.
Epidemiological correlation between COVID-19 epidemic and prevalence of α-1 antitrypsin deficiency in the world
Global Health & Medicine. 2021; 3(2):73-81.
Characteristics of patients with novel coronavirus disease (COVID-19) during the first surge versus the second surge of infections in Osaka Prefecture, Japan
Global Health & Medicine. 2021; 3(2):82-89.
Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan
Global Health & Medicine. 2021; 3(2):90-94.
Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus disease 2019
Global Health & Medicine. 2021; 3(2):95-101.
COVID-19 in Okayama Prefecture: Looking back and looking forward
Global Health & Medicine. 2021; 3(2):102-106.
Effective screening strategies for detection of asymptomatic COVID-19 travelers at airport quarantine stations: Exploratory findings in Japan
Global Health & Medicine. 2021; 3(2):107-111.
Combating COVID-19 as a designated hospital: Experience from Shanghai, China
Global Health & Medicine. 2021; 3(2):112-114.
Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19
Global Health & Medicine. 2021; 3(2):115-118.
Care for children's mental health during the COVID-19 pandemic in Japan
Global Health & Medicine. 2021; 3(2):119-121.
The effect of the COVID-19 pandemic on incidence and characteristics of pulmonary embolism
Global Health & Medicine. 2021; 3(2):122-124.
Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal influenza prevention and control?
Global Health & Medicine. 2021; 3(3):125-128.
Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review
Global Health & Medicine. 2021; 3(3):129-133.
Management of frailty under COVID-19 pandemic in Japan
Global Health & Medicine. 2021; 3(4):196-202.
COVID-19 and liver surgery in France, Italy, Japan, and the United States: A report of a single topic conference of Eastern and Western Association for Liver Tumors (EWALT) 2021
Global Health & Medicine. 2021; 3(4):240-242.
HIV testing in COVID-19 pandemic and beyond in Japan
Global Health & Medicine. 2021; 3(6):356-357.
Algeria's preparedness for Omicron variant and for the fourth wave of COVID-19
Global Health & Medicine. 2021; 3(6):413-414.
Interleukin-6 is upregulated and may be associated with myocardial injury in some patients who have recovered from COVID-19
Global Health & Medicine. 2022; 4(1):61-63.
COVID-19 in Japan: An update on national policy, research, clinical practice, and vaccination campaign
Global Health & Medicine. 2022; 4(2):64-66.
How did the Tokyo Metropolitan Government respond to COVID-19?
Global Health & Medicine. 2022; 4(2):67-70.
Reporting on the implementation to set up a "care and isolation facility" for mild COVID-19 cases in Tokyo
Global Health & Medicine. 2022; 4(2):71-77.
Public health responses to COVID-19 in Japan
Global Health & Medicine. 2022; 4(2):78-82.
Long COVID: current status in Japan and knowledge about its molecular background
Global Health & Medicine. 2022; 4(2):83-93.
For safe and adequate blood purification therapy in severe COVID-19 ‒ what we have learned so far
Global Health & Medicine. 2022; 4(2):94-100.
Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan
Global Health & Medicine. 2022; 4(2):101-107.
Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT
Global Health & Medicine. 2022; 4(2):108-115.
Trends in endotracheal intubation for patients with COVID-19 by emergency physicians
Global Health & Medicine. 2022; 4(2):116-121.
Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic caused by the Delta variant in Japan
Global Health & Medicine. 2022; 4(2):122-128.
Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan
Global Health & Medicine. 2022; 4(2):129-132.
The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics
Global Health & Medicine. 2022; 4(2):133-136.
Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system
Global Health & Medicine. 2022; 4(2):137-140.
Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan
Global Health & Medicine. 2022; 4(2):141-143.
Establishment of an emergency regulatory approval system in Japan in response to the COVID-19 pandemic and challenges in developing domestically produced vaccines
Global Health & Medicine. 2022; 4(2):144-145.